Back
Bragar Eagel & Squire investigates potential securities claims involving Ensign Group after Hunterbrook short report

Bragar Eagel & Squire investigates potential securities claims involving Ensign Group after Hunterbrook short report

The law firm said it is examining possible investor claims after a June 8 report alleged Ensign’s profits relied on inadequate patient care, understaffing and manipulation of quality metrics.

Fact Check
The Pomerantz press release directly and explicitly confirms the firm's investigation of Ensign Group investor claims following the Hunterbrook (June 8, 2026) and Muddy Waters (June 11, 2026) short-seller reports, each followed by a stock decline. The Orange County Business Journal independently corroborates the short-seller allegations and the sharp stock drop, and additional outlets (Morningstar, Lowey Dannenberg, kavout) reference the same events. All elements of the claim are supported by primary and independent sources.
    Reference: 12
Summary

Bragar Eagel & Squire said it is investigating potential claims on behalf of shareholders of The Ensign Group, Inc. (NASDAQ: ENSG) over whether the company may have violated federal securities laws or engaged in other unlawful business practices. The inquiry follows a June 8, 2026 short report by Hunterbrook alleging that Ensign Group’s business model relies on inadequate patient care and gaming quality metrics, and that profits depend on understaffing facilities while routing taxpayer dollars to executives and affiliates. The report also alleged that patients suffered and died as a result. Ensign shares fell $13.88, or 8.15%, to close at $156.42 on June 8, 2026, after the report was published. Bragar Eagel & Squire directed investors who purchased or acquired Ensign shares, suffered losses, or have relevant information to contact Brandon Walker or Melissa Fortunato about the matter.

Terms & Concepts
  • securities laws: Rules governing how companies disclose information to investors and how securities are offered and traded.
  • short report: A publication, often by a short seller or research firm, that presents negative claims about a company and can pressure its stock price.